Meidrix Biomedicals logo

Meidrix Biomedicals

Recent Finacing

Equity

Recent Raise

$1M

Amedrix GmbH develops and manufactures native collagen medical devices, including solutions, membranes, sponges and fleeces of form and thickness for soft-tissue defect regeneration, pursuing regulatory approvals and partner distribution.

Founded 2009
Bayern, Germany
11-50
Private
meidrix.de

Highlights

Focus Areas

Biotechnology
Manufacturing
Medical Device

Recent Investors

Financials

$1M

Total Raised

1

Funding round

2

Investors